Health

Aspirin is commonly used for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). Enteric coating, also known as “safety coating,” is believed to reduce gastrointestinal bleeding associated with aspirin use. However, the effectiveness and safety of enteric-coated aspirin compared to uncoated aspirin remain uncertain. In a recent study called ADAPTABLE, researchers aimed to determine the
0 Comments
The U.S. Food and Drug Administration (FDA) has granted authorization to the updated Novavax COVID-19 vaccine, allowing it to protect against hospitalization and death from circulating variants. This protein-based shot, targeting the XBB.1.5 strain as required by the FDA, serves as a non-mRNA option for the upcoming 2023-2024 season. The authorization comes after the FDA’s
0 Comments
A groundbreaking study presented at the American Society for Radiation Oncology (ASTRO) annual meeting revealed that Stereotactic Ablative Body Radiotherapy (SABR) is proving to be an effective and noninvasive alternative treatment for primary renal cell carcinoma (RCC) patients who are not suitable candidates for surgery. The FASTRACK II trial, a prospective phase II study involving
0 Comments
Obesity has become a prevalent issue, not only among adults but also among children and adolescents. The American Academy of Pediatrics (AAP) recognizes the importance of addressing this issue and has recently released its first clinical practice guideline for the treatment of obesity in young patients. Anti-obesity medications are now recommended as an adjunct to
0 Comments
Senator Dianne Feinstein, a champion of reproductive rights and progressive healthcare causes, has passed away at the age of 90. Her unwavering dedication to public service and perseverance amidst health challenges leaves behind a remarkable legacy. Throughout her illustrious political career, Senator Feinstein made significant contributions to a wide range of issues. Elected to the
0 Comments
The landscape of LGBTQ+ healthcare has often been portrayed as a battle between states restricting access to gender-affirming care and those championing the protection of this crucial healthcare need. While it is true that access to transgender care continues to expand in the majority of the United States, this narrative overlooks the far-reaching health disparities
0 Comments
Recent research from a Lancet Commission has shed light on the profound gender inequalities that affect women’s access to cancer prevention, detection, and care. The report emphasizes that cancer remains one of the leading causes of premature death among women worldwide. Shockingly, 2.3 million women die prematurely from cancer each year, and a significant number
0 Comments
The Food and Drug Administration (FDA) has expressed grave reservations about an investigational amyotrophic lateral sclerosis (ALS) treatment called debamestrocel — also known as MSC-NTF or NurOwn — developed by BrainStorm Cell Therapeutics. With an advisory committee meeting scheduled for this week, the FDA has deemed the drug’s application as scientifically incomplete and lacking evidence
0 Comments